mckca_Pressrreleasetitle

Press Releases

Asset Publisher

McKesson Canada Named One of Montreal's Top Employers for the Seventh Consecutive Year

Montreal, QC (February 27, 2024) – For the seventh consecutive year, McKesson Canada has been recognized as one of Montreal's Top Employers for 2024. The award is in recognition of the organization’s leading practices and benefits that enable employees to take charge of their health and wellbeing, its charitable giving, and for creating a flexible work culture where employees feel welcomed, valued and included.

“At McKesson Canada, our amazing talent are innovative and driven thinkers representing a wealth of backgrounds, perspectives, and experience,” says Joan Eliasek, President, McKesson Canada. 

“Together, we set the foundation for an outstanding work culture that draws on the richness of our diverse viewpoints and skillsets to help us grow, personally and professionally; foster a sense of belonging; and advance health outcomes for all.”

McKesson Canada plays a pivotal role in Canadian healthcare by providing solutions to manufacturers, pharmacies, hospitals and various healthcare institutions who serve the needs of patients every day. It brings together clinical knowledge, process expertise, technology and resources to help customers and partners fundamentally change the cost and quality of healthcare in Canada.  

What sets McKesson Canada apart
Montreal’s Top Employers evaluated McKesson Canada in a number of categories, including community involvement, physical workplace and work atmosphere, as well as work environment and culture.

At McKesson Canada, employees can take advantage of charitable donation matching and volunteering grants available to eligible charities, and everyone is encouraged to join our employee resource groups (ERGs). These peer-led, company-sponsored groups promote, develop, and advance employees connected by shared cultures, backgrounds, and interests, and are dedicated to advancing diversity and inclusion within the organization.
After a recent and extensive renovation, McKesson Canada’s Montreal office now has more areas for social interaction (such as a game room, fitness centre and Centraide store), more meeting rooms and collaboration space, and more technology, allowing for even greater connectivity and productivity in the workplace. 

Through its several programs and employee initiatives, McKesson Canada has cultivated a culture of caring, meaning and belonging, with the goal of being the best place to work in healthcare. To learn more about why McKesson Canada was selected as one of Montreal’s Top Employers, read
the complete employer review. For more information on career opportunities with McKesson Canada, visit mckesson.ca/en/careers.

About Montreal’s Top Employer Awards
First published in 2006, Montreal's Top Employers is an annual competition organized by the editors of Canada's Top 100 Employers. This special designation recognizes the employers in Greater Montreal that lead their industries in offering exceptional places to work. Employers are evaluated by the editors of Canada's Top 100 Employers using the same eight criteria as the national competition: (1) Physical Workplace; (2) Work Atmosphere & Social; (3) Health, Financial & Family Benefits; (4) Vacation & Time Off; (5) Employee Communications; (6) Performance Management; (7) Training & Skills Development; and (8) Community Involvement. Employers are compared to other organizations in their field to determine which offer the most progressive and forward-thinking programs. Any employer with its head office or principal place of business in Greater Montreal may apply for this competition. Employers of any size may apply, whether private or public sector.      

About McKesson Canada 
McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable. 
Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.

For more information: 
Sybil Millar
Senior Advisor, Media Relations and External Communications
media@mckesson.ca  

Roche Canada and McKesson Canada Inaugural Innovation Challenge Enhances the Patient Experience

MISSISSAUGA, ON - January 11, 2024 - Hoffmann-La Roche Limited (Roche Canada) is proud to announce a dynamic collaboration with McKesson Canada (McKesson) which has resulted in solutions that will optimize the patient journey and potentially shorten overall time to therapy.

The two industry leaders brought collaborative teams together for an intensive six-week innovation challenge aimed at removing barriers, enhancing the patient experience, streamlining administrative processes, and expediting reimbursement within existing patient support programs. This collaboration demanded a creative approach to strategically design solutions within the constraints of available resources.

When a patient is diagnosed with a chronic condition or disease like Multiple Sclerosis (MS) or cancer, it can be challenging to navigate the complex healthcare systems. Patient Support Programs (PSPs) work to simplify the process and ease the patient’s experience.

“Roche created this innovation challenge to explore what could be possible in the patient support program space and to see what - with an open-minded partner like McKesson Canada - we could do differently, better, faster for patients,” said Roger Tam, Vice President, Legal, Compliance, and Innovation at Roche Canada. “Design thinking empowered Roche Canada and McKesson Canada employees to frame opportunities and create solutions that will deliver significant value to all stakeholders, especially patients.”

The innovation challenge culminated in a pitch competition, where teams presented their proposals to a seasoned panel of leaders from both Roche Canada and McKesson Canada. The pitches underwent rigorous evaluation, resulting in the prioritization of the highest-scoring proposal for implementation over the next six to 12 months. Ultimately, the panel found all solutions to be compelling enough for implementation; it was simply a matter of determining the optimal timeline for each.

The two winning innovations addressed the cumbersome administrative challenges experienced by both patients and healthcare providers during PSP enrolment. Through streamlined processes, these solutions not only minimize time and redundancy for all stakeholders but also significantly accelerate access to vital therapies.


“When you have a patient with a complex disease, you do everything you can to get them to critical treatment as fast as you can,” said Rebecca Yu, Vice President/General Manager, Biopharma Operations & Customer Experience, McKesson Canada. “The Roche McKesson Innovation Challenge shows what is possible when you change your approach, share a common goal and come together with committed partners. We are tremendously proud of our teams and inspired by the value they have created with new solutions that will positively impact care and experience for patients!”

McKesson Canada is a Patient Support Program partner to Roche Canada and works to simplify a patient’s health journey by helping them to navigate the various healthcare systems, including supporting the administration process to ensure timely access to treatment.

The success of this innovation challenge not only underscores Roche Canada and McKesson Canada’s ability to swiftly implement ideas but also marks a pivotal step towards fostering a proactive culture of idea sharing, collaboration and innovation. Roche Canada and McKesson remain committed to revolutionizing PSPs and setting a new standard for excellence in patient care and experience.
 

About Roche Canada
Patients and science are at the heart of everything we do. At Roche, our passion for science and our commitment to relentlessly pursuing the impossible for patients has made us one of the world’s leading pharmaceutical, in vitro diagnostics, and healthcare technology companies. And we’re adding our expertise in new areas, such as artificial intelligence, real world data collection and analysis and collaborating with many different sectors and industries.

We're an innovator across major disease areas, including oncology, infectious diseases, diabetes, ophthalmology, and diseases of the central nervous system.

Roche Canada was founded in 1931 and employs more than 1,800 people across the country through its Pharmaceuticals division in Mississauga, Ontario as well as its Diagnostics and Diabetes Care divisions in Laval, Quebec. For more information, please visit www.RocheCanada.com, or follow Roche Canada on LinkedIn, or on Twitter @RocheCanada.
 

About McKesson Canada
McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca.

 

-30-

 

For information, contact:

Jennifer Mota
Roche Canada
Jennifer.mota@roche.com

Michelle Lee-Gracey
McKesson Canada
media@mckesson.ca

McKesson Canada Opens New State-of-the Art Distribution Centre in Surrey British Columbia

Supporting British Columbia’s Future Health

Surrey, BC (June 8, 2023) – To support British Columbia’s rising healthcare needs, McKesson Canada opens a new state-of-the-art, 233,000 square-foot facility in Surrey, British Columbia (BC). The new distribution centre (DC) delivers pharmaceutical medications, vaccines, specialty pharmaceuticals, and over-the-counter products to over 1,300 hospitals, clinics, and pharmacies across BC. McKesson Specialty Pharmacy on site manages complex specialty medications, providing quality care for patients across the province.

 

Image

- New 233,000 square-foot facility ensures expanded capacity to support provincial medication delivery needs long-term and strengthens medication delivery infrastructure

- McKesson Canada’s new distribution centre features industry-leading automation to accelerate fulfillment and increase efficiency and productivity

- Integration of on-site Specialty Pharmacy campus ensures support in rise of complex therapies

As part of McKesson Canada’s distribution modernization plan, $175 million dollars was invested in the development and design of the Surrey DC to integrate industry-leading automation technology and strengthen efficiency and productivity. The DC uses best-in-class technology and processes to increase accuracy, protect against volume fluctuations and doubles potential capacity to over 235,000 units shipped daily. This investment ensures McKesson Canada can meet Canada’s rising need for complex specialized medications and respond to BC’s future healthcare demands, particularly the expected 63 per cent[i] rise in seniors over the next 20 years, who typically have more complex conditions.

“Today, we are showcasing our unwavering dedication to improve health outcomes of Canadians. From strategic concept to operations, McKesson Canada’s Surrey distribution centre is a showcase of innovation that blends the state-of-the-art technology and optimized processes that secure our capacity to support the growing healthcare needs of British Columbians for the long term,” said Joan Eliasek, President, McKesson Canada. “We take great pride in our investment in British Columbia and in our responsibility to deliver lifesaving medications reliably and safely across the province for many years to come.”

 

State-of-the-Art Technology, Processes and Automation

State-of-the-art automation technology enables more efficient and accurate product picking. The new DC utilizes a system that picks products from over 22,000 storage containers, delivering them directly to the operators who ensure quality and accuracy. The automation process allows for vast quantities of product to flow through the distribution system, with real-time monitoring and forecasting of required product volume levels. Picked products are released and sequenced according to delivery route, all through automation to ensure the right product gets to the right destination for precise just-in-time delivery.

Significant investment has also been made in cold chain storage to support Canada’s rising need for more complex medications that require fridge and freezer storage, such as COVID-19 vaccinations.

The Surrey DC is the last of McKesson Canada’s transformation and modernization initiatives in Western Canada, including building new Edmonton and Winnipeg DCs. Reaching this milestone means that McKesson Canada is prepared to support and react quickly in times of environmental crisis or emergencies like wildfires or flooding. Each McKesson Canada DC in Western Canada has contingency planning to be able to support provinces in the event of a disruption or crisis.

 

Bedrock of Community and Independent Pharmacy

Just-in-time delivery is a hallmark of the McKesson Canada distribution system, creating an infrastructure that allows for continual flow of goods into the community and reliable access to medication. McKesson Canada’s distribution system has been a key enabler for independent pharmacy. The modernization of the Surrey DC processes, tools and equipment support operational excellence and enhances our customer offering.

“The complexity of just-in-time delivery within an ecosystem that delivers much needed medication to every community in Canada, the next day, every day is extraordinary,” says Jean-Philippe Blouin, Senior Vice-President Pharmaceutical Distribution & Operations, McKesson Canada. “The value and enhanced features of our new Surrey distribution centre ensures that we provide reliable service and further demonstrates our commitment to our patients and our customers in BC.”

 

The Rise of Specialized Medication Needs

The use of specialty medications and therapeutic treatments for both acute and chronic care patients continues to rise in Canada. In 2021, specialty drugs had a 9.5 per cent growth rate compared to traditional drugs at 2.9 per cent.[ii] The innovative McKesson Specialty Pharmacy provides care to patients from a wide range of therapeutic specialties such as neurology, oncology, immunology and ophthalmology. Molecules are compounded on site in state-of-the-art cleanrooms where hazardous and non-hazardous medications are handled in sterile environments. The integration of the McKesson Specialty Pharmacy in the Surrey DC allows for more efficient access and delivery to patient’s homes, hospitals, and infusion clinics.

 

Environmental Focus

Situated on 14 acres of land, the new DC office space was designed with consideration for environmental sustainability.  The new DC features LED low energy lighting, low flow water fixtures, underground rainwater collection, native landscaping to support local birds and insects and electric vehicle charging stations.

The Surrey DC employs 180 people and supports additional jobs in partner businesses including transportation.

 

About McKesson Canada

McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca

For more information: media@mckesson.ca  


[i] Ip, Frank and Lavoie, Sebastien. ”PEOPLE 2020: BC Sub-Provincial Population Projections.” Government of British Columbia, BC Stats.,https://www2.gov.bc.ca/assets/gov/data/statistics/people-population-community/population/people_population_projections_highlights.pdf

[ii]“2022 Drug Data Trends & National Benchmarks.” TELUS Health. Pg. 12, https://plus.telushealth.co/blogs/health-benefits/wp-content/uploads/TELUS-Health-Drug-Data-Trends-Report-2022.pdf 

Publish Date
6/8/23

McKesson Canada’s INVIVA Sets New Standard of Excellence for Oncology in Community Infusion Clinics

Mississauga, ON (March 9, 2023) – McKesson Canada’s INVIVA has met Accreditation Canada’s Qmentum Accreditation Program requirements to become the first and only accredited national private infusion clinic network in oncology. The Cancer Care Accreditation puts INVIVA through the same accreditation process widely used by hospitals who turn to Accreditation Canada to monitor system-wide standards of excellence in quality, safety, and care.

“Accreditation is a continuous process of meeting standards of quality. INVIVA’s successful accreditation sends a clear signal to their staff, patients, and other health care providers of their commitment to quality,” says Pamela Daw, Accreditation Canada. “This external recognition of their competence elevates their profile and strengthens confidence in their services.”

In total six accreditations were awarded to INVIVA: Cancer Care, Home Care Services, Ambulatory Care Services, Medication Management, Infection Prevention and Control, and Leadership Standards. The rigorous evaluation process included over 700 standards of measurement in the areas of safety practices, external peer surveys from medical and healthcare teams, patient satisfaction ratings, and consistent adherence to high quality clinical processes.

INVIVA patients are supported by a robust network of over 300 Registered Nurses across 76 clinics, with extensive experience in administering specialty and biologic drugs intravenously, subcutaneously, and intramuscularly with specialized training in multiple therapeutic areas, including immunology, oncology, and neurology. A team of clinicians, patient care coordinators and facility employees round out the INVIVA care team. To date, there are approximately 18 oncology medications within the INVIVA network, with capability to expand the treatment portfolio to further support complex oncology treatments.

"Providing Canadian patients with convenient, quality and accessible care, closer to home is at the forefront for our INVIVA team,” says Lee Steele, Vice President, INVIVA & Chief Nursing Officer. “This new oncology distinction validates our commitment to patient care in one of the most complex therapeutic areas. Accreditation provides assurances to our patients that our standards are on par with the medical care they receive in a hospital setting.”

As a McKesson Canada Company, INVIVA is part of the care network that is dedicated to helping a patient navigate an often overwhelming and complex system. From diagnosis to patient support programs, and state-of-the-art specialty medication distribution, the integrated processes at McKesson work to ensure a seamless end-to-end patient experience that seeks to remove barriers to timely and convenient access to care.

“The reality of healthcare today is that specialized drug treatments and biologicals are more prevalent as the best course of treatment for patients living with a complex condition. This is good news for patients who can benefit from more personalized treatment and medication plans which can ultimately improve their quality of life,” said Ramy Ayad, Senior Vice-President, Biopharma and Provider Solutions, McKesson Canada.  “Accreditation Canada’s designation for INVIVA speaks to our mission to be a leader in infusion therapy, particularly in areas as complex as oncology. Congratulations to the nurses and team at INVIVA on this important accreditation driven by your hard work, and feedback from our patients and medical peers!”

McKesson Canada's INVIVA clinics successfully completed the Qmentum Accreditation Program and received full accreditation at all locations across Canada now through December 2026.

 

About INVIVA

Established in 2013, today INVIVA is Canada's largest private infusion network with 76 INVIVA clinics that provide patients with specialized therapy in a caring and compassionate setting. INVIVA experts work directly with manufacturers to bring specialty therapies and nursing services to patients in need while improving access. They engage with health care providers to improve the patient experience and make it easier for everyone to manage complex diseases. Its team of highly trained seasoned nurses help manage various therapeutic areas, including gastroenterology, rheumatology, geriatrics, pediatrics, and more. In 2023, INVIVA was awarded accreditations in Cancer Care, Ambulatory Care, Home Care Services, Leadership, Infection Prevention and Control, and Medication Management making it the only national private infusion network with accreditation.

 

About McKesson Canada

McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca

 

About Accreditation Canada

Accreditation Canada is a not-for-profit organization that works with patients, policy makers and the public to improve the quality of health and social services for all. Accreditation Canada works closely with health and social services organizations in Canada and abroad to develop a sustainable culture of improvement that betters safety and efficiency, working to save and improve lives. More than 1,000 health and social service organizations and 7,000 sites in Canada and around the world have been accredited through our programs and services, leading to safer, quality health care for those who matter most; patients and their families.

 

For more information:

Andrew Campbell
Media Relations
media@mckesson.ca

 

Publish Date
3/9/23

McKesson Canada Ranked One of Montreal's Top Employers for the Sixth Consecutive Year

MISSISSAUGA, ON, February 2023 – McKesson Canada is proud to announce today that it has been recognized as one of "Montreal's Top Employers" for 2023 by the editors of Mediacorp Canada Inc. marking the sixth consecutive year that the company has received this award.

“We are proud that McKesson has been recognized as a top employer in Montreal for the sixth year in a row, where we play an important role in this dynamic city. People join McKesson Canada because they want to contribute to our mission to advance the health outcomes of all Canadians. Employees stay because of our values and a deep sense of belonging, built through an unwavering commitment to our purpose and to the customer. Congratulations to Team McKesson for this extraordinary achievement and thank you for making our company a great place to work!” said Joan Eliasek, President of McKesson Canada.

McKesson Canada has introduced a number of new and innovative tools over the years to help employees develop their career, grow the company, and feel empowered to contribute. Some of those include:

Professional development

  • At McKesson, we believe in our competency “Grow Self and Others”. Engrained in the company culture is a commitment to development and professional growth supported by tools and resources such as employee training programs, people leader training focused on team development, succession planning, educational assistance, a comprehensive learning portal and learning on the job to name a few. 

Engagement

  • Inclusion and diversity networks open to all McKesson Canada employees as we continue to build a workplace where each of us can bring our whole self to work and where our diversity of backgrounds and experience is valued.
  • McKesson Café, our online networking platform where employees can meet new people from across the organization.
  • Workplace flexibility that promotes balance is key to McKesson Canada’s success as a top employer facilitated by our current Office as a Destination model.

Charitable giving

  • McKesson Canada employees can take advantage of charitable donation matching and volunteering grants available to eligible charities.

Health and wellness options

  • Generous health benefits, including the virtual medicine service, EQ Care.
  • Employee and family assistance program, for free counselling, nutritional, legal, and financial advice.
  • A mental health coach, who supports employees to navigate challenging situations.

 

In addition to the "Montreal's Top Employers" 2023 award, McKesson Canada was awarded the Women in Governance Parity Certification which recognizes organizations that are leading the way in achieving gender parity both in 2021 and in 2022.

 

Top Montreal Employer Award

First published in 2006, Montréal's Top Employers is an annual competition organized by the editors of Canada's Top 100 Employers. This special designation recognizes the employers in Greater Montréal that lead their industries in offering exceptional places to work. Employers are evaluated by the editors of Canada's Top 100 Employers using the same eight criteria as the national competition: (1) Physical Workplace; (2) Work Atmosphere & Social; (3) Health, Financial & Family Benefits; (4) Vacation & Time Off; (5) Employee Communications; (6) Performance Management; (7) Training & Skills Development; and (8) Community Involvement. Employers are compared to other organizations in their field to determine which offer the most progressive and forward-thinking programs. Any employer with its head office or principal place of business in Greater Montreal may apply for this competition. Employers of any size may apply, whether private or public sector.

 

About McKesson Canada

McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable.

Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca

For more information:

Andrew Campbell

media@mckesson.ca

Publish Date
3/8/23

Joan Eliasek Named New President of McKesson Canada

Mississauga, ON - Feb 9, 2023 - McKesson Canada is pleased to announce the appointment of veteran executive Joan Eliasek as President of McKesson Canada. Eliasek succeeds Rebecca McKillican who has led the company since August 2020.

Eliasek’s wealth of leadership experience spans over 25 years within the healthcare sector and McKesson Corporation, having held senior leadership roles in areas ranging from operations, marketing, supplier management to extended care sales and customer experience.

As President, Eliasek leads McKesson's diversified portfolio of healthcare businesses in Canada including pharmaceutical distribution operations, biopharma and provider solutions, McKesson's network of independent pharmacies (I.D.A., Guardian, Remedy'sRx, The Medicine Shoppe, Uniprix and Proxim), e-commerce retailer Well.ca, and the Rexall Pharmacy Group.

“I am honoured to be leading a passionate team dedicated to improving the health outcomes of Canadians,” Eliasek said.  “McKesson Canada is an essential part of the Canadian healthcare system, whether we are delivering much needed medications to patients across the country, strengthening our supply chain systems, or helping patients navigate specialized medication therapies. As healthcare becomes increasingly more complex, our position within the healthcare ecosystem offers us a unique opportunity to make a positive and lasting impact.”

Eliasek holds a Bachelor of Arts degree in Political Science and Business Administration from the University of Iowa. She has served on several boards in the healthcare industry, including the Healthcare Industry Distributors Association (HIDA), the HIDA Educational Foundation and the Global Healthcare Exchange. She also served as a long-time advisor to the Professional Women in Healthcare (PWH) board. In 2018, she was recognized as the first recipient of the Anne Eiting Klamar Leadership Award of Distinction and in 2023 she is being named to the Medical Distributor Hall of Fame by Repertoire Magazine.

 

About McKesson Canada

McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.

Publish Date
2/9/23

McKesson Canada’s independent pharmacies Guardian, I.D.A., Remedy’sRx and The Medicine Shoppe Pharmacies welcome decision to prescribe for minor ailments

Mississauga, ON (January 17, 2023) - Pharmacists at McKesson Canada’s independent pharmacy network including Guardian, I.D.A, Remedy'sRx and The Medicine Shoppe in Ontario can now prescribe and treat 13 minor conditions, including cold sores, pink eye, hemorrhoids, hives and urinary tract infections, among others.

Patients can now walk into their local pharmacy and receive assessment and treatment from their pharmacist for the following 13 conditions:

  • hay fever
  • oral thrush
  • pink eye
  • dermatitis
  • menstrual cramps
  • acid reflux 
  • hemorrhoids
  • cold sores
  • impetigo
  • insect bites and hives
  • tick bites
  • sprains and strains
  • urinary tract infections (UTIs)

 

By allowing pharmacists to support patients with these needs, it increases access to quality care and takes pressure off the health system like hospitals, primary care clinics and emergency rooms.

 

"Our independent pharmacists at Guardian, I.D.A., Remedy'sRx and The Medicine Shoppe are standing by to help provide greater convenience and choice for their patients to obtain quality healthcare services where they need them the most,” says Smita Patil, Vice President, Retail Member Relations and Professional Affairs at McKesson Canada. “By using their expertise to assess and treat minor conditions, pharmacists help patients get the care they need sooner and closer to home.”

 

About McKesson Canada

McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable.

Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca

 

For more information:
Andrew Campbell
Media Relations
media@mckesson.ca

Publish Date
1/17/23

McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes

McKesson EvolveHealth Digital Ecosystem offers innovative solutions at every step of the specialty patient journey

MISSISSAUGA, ON, Nov. 17, 2022 - McKesson Canada's Biopharma and Provider Solutions business is proud to share the launch of McKesson's EvolveHealth Digital Ecosystem (EvolveHealth). EvolveHealth is a suite of digital solutions designed to seamlessly connect health care providers, private payers, specialty patients, and pharmaceutical companies to help simplify and enhance the patient experience and deliver better patient outcomes.

McKesson Canada (CNW Group/MCKESSON CANADA)

 

One of the ongoing challenges faced by both health care providers and Canadians affected by rare or complex diseases, is navigating a complex system which can sometimes delay access to life-saving therapeutic treatments. To better support health care providers and specialty patients, EvolveHealth offers innovative solutions that help alleviate these challenges and create a more accessible, specialized, and personalized care journey.

As a digital suite, EvolveHealth supports patients at every step of their journey. It simplifies their access to treatment, streamlines financial assistance and co-pays, enhances adherence to treatment plans and provides patients with data and insights on their progress to improve outcomes. For health care providers and pharmaceutical companies, EvolveHealth delivers actionable insights, offers seamless communication between different teams and individuals, and highlights real-world evidence to help improve patient care and outcomes. EvolveHealth also builds on McKesson Canada's partnerships with leading health technology and platforms like KEEP (the award-winning modern medicine cabinet for complex medication management) to help simplify access to treatment and help improve the patient experience.

"McKesson Canada is proud to be a long-standing partner to the pharmaceutical industry, and we're excited to introduce the EvolveHealth Digital Ecosystem as part of our aspiration to improve patient outcomes," said Ramy Ayad, Senior Vice-President, Biopharma and Provider Solutions. "This is a digital suite aimed at improving care for specialty patients, while simultaneously enhancing health care providers, pharmaceutical companies and private payer efficiencies and managing complexities related to specialty medications and treatments."

Digital innovations and solutions to simplify and improve patient outcomes is a foundational pillar for McKesson Canada's Biopharma and Provider Solutions teams. McKesson Canada is focused on harnessing EvolveHealth to positively impact the lives of Canadians and advancing better health outcomes for all.

About McKesson Canada

McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca

 

For further information: Andrew Campbell, Media Relations, media@mckesson.ca

Publish Date
11/17/22

McKesson Canada's Independent Pharmacies Guardian, I.D.A., Remedy’sRx and The Medicine Shoppe Pharmacies Launch Annual Flu Vaccination Campaigns

Today, McKesson Canada’s retail banner group pharmacies, including Guardian, I.D.A, Remedy'sRx and The Medicine Shoppe launched their annual flu shot campaign.

 “Our independently owned community pharmacies are ready to deliver the flu vaccine to Canadians who wish to protect themselves and their loved ones,” said Smita Patil, Vice-President of Retail Member Relations and Professional Affairs, McKesson Canada. “Canadians should feel assured knowing their local pharmacist will be able to provide flu shots with high quality care, knowledge, and a safe environment that prioritizes the health and well-being of patients.”

Every year, tens of thousands of Canadians get sick with the flu. While most people will recover after contracting the flu, it can be life-threating for people at high risk such as children, seniors, and those with chronic health conditions.

Getting vaccinated against the flu every year is an important part of keeping Canadians healthy. The vaccine not only protects individuals against some strains of the virus, but also reduces the severity of symptoms for those who do get the flu.  It takes a community to prevent the spread of influenza and for about every 20 people that get a vaccine, one case is prevented.

Our Independent community pharmacies are proud to play a vital role in the Canadian healthcare industry and in our greater society. Contact your local community pharmacist today to schedule your free flu vaccine. Make an appointment today by visiting the websites of GuardianI.D.ARemedy'sRx or The Medicine Shoppe to find the closest pharmacy near you. Availability by province and pharmacy location may vary.

 

About McKesson Canada

McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.

 

For more information:

Andrew Campbell

Media Relations

media@mckesson.ca

Publish Date
10/13/22

Les pharmacies affiliées à Proxim et Uniprix lancent leur campagne annuelle de vaccination contre la grippe

Montréal (Québec), le 5 octobre 2022 — Les pharmacies affiliées à Proxim et Uniprix lancent leur campagne annuelle de vaccination contre la grippe.

« Au cours des dernières années, nos pharmaciens communautaires ont su démontrer qu’ils sont partie intégrante du système de santé québécois », a déclaré Erick Gagné, président-directeur général, Proxim et Uniprix. « Après avoir participé à l’effort de vaccination contre la COVID-19, les pharmaciens sont prêts, encore cette année, à vacciner les Québécois qui souhaitent se protéger et protéger leurs proches contre la grippe. »

L'activité grippale dans l'hémisphère Sud ayant été plus précoce par rapport aux années précédentes, la campagne de vaccination contre l'influenza a été devancée cette année et débutera le 5 octobre. Chaque année, des milliers de Québécois souffrent de la grippe, ce qui engorge davantage les hôpitaux et le système de santé. Bien que la plupart des gens se rétablissent après avoir contracté la grippe, celle-ci peut menacer la vie des personnes à risque, notamment celle des enfants, des aînés et des personnes atteintes de maladies chroniques.

Consultez les sites internet de Proxim et d’Uniprix afin de prendre votre rendez-vous dès aujourd’hui dans la pharmacie la plus près de chez vous. Profitez-en pour recevoir, en même temps et de façon sécuritaire, le vaccin contre la COVID-19.

*Les pharmaciens propriétaires affiliés à Proxim et Uniprix sont les seuls responsables de l’exercice de la pharmacie.

 

À propos de McKesson Canada

McKesson Canada est un chef de file diversifié en matière de services de soins de santé qui se consacre à l’avancement des résultats relatifs à la santé des patients du monde entier. Nos équipes collaborent avec les sociétés biopharmaceutiques, les fournisseurs de soins, les pharmacies, les fabricants, les gouvernements et d’autres intervenants afin de fournir des perspectives, des produits et des services permettant de rendre les soins de qualité plus accessibles et abordables. Apprenez-en davantage sur l’impact de McKesson Canada sur pratiquement tous les aspects des soins de santé sur www.mckesson.ca.

 

Renseignements

Melissa Turgeon

Relations médias pour le Québec

media@mckesson.ca

(514) 601-7280

Publish Date
10/5/22

McKesson Canada's Guardian, I.D.A., Remedy’sRx® and The Medicine Shoppe® Pharmacies Launch Annual Flu Vaccination Campaigns

Mississauga, ON, October 18, 2021 — Today, McKesson Canada’s retail banner group pharmacies, including Guardian®, I.D.A®, Remedy'sRx® and The Medicine Shoppe® launched their annual flu shot campaign.

 

“Our independently owned community pharmacies are at the ready, more than ever following a successful COVID-19 vaccination campaign, to deliver the flu vaccine to Canadians who wish to protect themselves and their loved ones,” said Elyse Desmeules Vice-President of Member and Retail Pharmacy Services, McKesson Canada. “Canadians should feel assured knowing their local pharmacist will be able to provide flu shots with high quality care, knowledge, and a safe environment that prioritizes the health and well-being of patients.”

 

Every year, tens of thousands of Canadians get sick with the flu, putting extra pressure on hospitals and health care systems across the country, which have been strained by the COVID-19 pandemic. While most people will recover after contracting the flu, it can be life-threating for people at high risk such as children, seniors, and those with chronic health conditions.

 

McKesson Canada's banner pharmacies are introducing safety measures to ensure patients feel safe and secure when receiving their flu shot. Depending on participating locations, this may include appointment scheduling, increased sanitation measures and hand sanitizing stations. Local guidelines implemented to protect the public against COVID-19 will also continue to be adhered to, including physical distancing, reduced store capacity and the wearing of face masks or coverings.

 

Protect yourself and your community. Make an appointment today by visiting the websites of Guardian®, I.D.A®, Remedy'sRx® or The Medicine Shoppe® to find the closest pharmacy near you. Availability by province and pharmacy location may vary.

 

– 30 –

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the health care industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other health care institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada.

 

For more information:

Andrew Forgione

Media Relations and Public Affairs Andrew.Forgione@mckesson.ca

905.671.4586

 

Publish Date
10/18/21

McKesson Canada Launches Full-Suite Digital Offering for Patients and Healthcare Professionals

Industry-leading partnership with Auxita simplifies the specialty patient journey

MISSISSAUGA, ON, June 16, 2021 /CNW/ - Today, McKesson Canada is pleased to announce Canada's most robust set of integrated digital solutions intended to enhance specialty physicians' ability to support their patients through their entire healthcare journey. This initiative builds on our ongoing efforts to provide better digital offerings for Canadians.

Canada’s leading end-to-end EMR connected digital network (CNW Group/MCKESSON CANADA)

Canada’s leading end-to-end EMR connected digital network (CNW Group/MCKESSON CANADA)

 

"Managing a patient who requires a specialty medication entails detailed planning and an investment in time and resources to adequately diagnose and provide treatment," said Ramy Ayad, Senior Vice-President, Specialty Health, McKesson Canada. "Our goal with today's announcement is to alleviate the administrative burden on healthcare professionals in areas such as medication access, workflow and communication, so that more time can be spent on what matters most – caring for patients."

 

A strategic partnership delivering market-leading digital capabilities

McKesson Canada, in partnership with leading Canadian technology firm Auxita, is expanding modern digital capabilities to simplify the patient journey. These solutions and capabilities will enable digital connectivity into Patient Support Programs (PSPs), streamlining the clinical workflow and patient experience to navigate complexities related to specialty medications and providing real time data on where the patient is on their treatment journey.

The technology facilitates patient to physician communication and eliminates administrative tasks, creating significant program efficiencies, enhancing the patient experience and shortening the amount of time to receive therapy. The platform will be Electronic Medical Record (EMR) agnostic and will be available for providers who do not have compatible EMRs.

"The Auxita platform is a comprehensive digital health care ecosystem. It delivers actionable insights, evidence-based pathways, simplified enrolment, and seamless communication to improve patient care," said Matt Cahill, CEO at Auxita. "We are looking forward to this partnership positively impacting the lives of Canadians, as we simplify the specialty healthcare experience."

 

A new, simplified specialty patient journey

Unlike existing solutions on the market today, the Auxita platform integrates directly into the existing office workflow. It seamlessly connects with EMRs to provide real time data on where the patient is on their treatment journey.

"As the largest technological initiative in the history of McKesson Canada Specialty Health, the new platform offers intelligent condition-specific alerts and reminders, getting patients started on a treatment plan sooner where a prescription is already available, and creates patient programs that support better treatment outcomes," continued Ayad.

McKesson Canada expects all digital capabilities to be fully operational by December 2021. For more information about this initiative, please contact media@mckesson.ca.

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, our biopharma partners, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

About Auxita

Auxita is a secure digital platform that seamlessly integrates with Electronic Medical Records to link patient data and clinical information across multiple systems. It connects doctors, patients, and patient support programs while eliminating the administrative tasks that can overwhelm today's healthcare providers. Auxita has an established footprint in Canada's healthcare sector and collaborates with strategic partners to ensure a consistent and secure flow of information throughout the patient journey. For more information on Auxita's next-generation medical technology that leads to better care, visit www.auxita.com.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586

Publication Date
21-06-16

McKesson Canada's IDA®, Guardian®, Remedy's Rx® and The Medicine Shoppe® Pharmacies Ready to Protect Canadians Against the Flu

Enhanced health and safety measures implemented to keep patients and employees protected during flu season

 

MISSISSAUGA, ON, Oct. 5, 2020 /CNW/ - Today, McKesson Canada's Retail Banner Group, which includes pharmacies under Guardian®, IDA®, Remedy's Rx® and The Medicine Shoppe® banners, are launching their annual flu shot campaign.

"Community pharmacists play an integral role in our healthcare system, forming a critical part in the fight against the spread of communicable diseases," said George Jeffrey, Senior Vice-President, Retail Banner Group, McKesson Canada.  "This year, McKesson Canada's banner pharmacies are introducing safety measures in addition to COVID-19 health and safety protocols, to ensure patients feel secure when receiving their flu shot."

It is widely anticipated that this year, there will be significant demand for the flu shot, as Canadians actively do their part to protect themselves and their loved ones this flu season. Guardian®, IDA®, Remedy's Rx® and The Medicine Shoppe® are implementing several new tools to help facilitate an easier, more efficient and safe flu shot process this year, including:

  • Appointment scheduling*
  • Flu best practices during the COVID-19 pandemic, such as social distancing, personal protective equipment, capacity limits and disinfection during flu immunization;
  • Enhanced pharmacist education through webinars on best practices;
  • QR code accessible electronic flu consent forms*

*in participating pharmacies only

The flu shot protects individuals against some strains of influenza virus and can be passed on before showing symptoms. This increases the likelihood of patients requiring physician office visits, potential hospital stays or in some cases, death. Getting vaccinated against the flu every year is an important part of keeping Canadians healthy. Contact your local community pharmacist today to schedule your free flu vaccine.

Please visit your local Guardian®, IDA®, Remedy's Rx® or The Medicine Shoppe® website to find the closest pharmacy near you.

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586

Rexall®, IDA®, Guardian®, Remedy's Rx® and The Medicine Shoppe® to Provide Safe and Convenient Access to COVID-19 Testing in Select Locations Across Ontario

McKesson Canada supports Government of Ontario decision to allow COVID-19 testing in pharmacies

 

MISSISSAUGA, ON, Sept. 23, 2020 /CNW Telbec/ - As the fight against COVID-19 continues, select Rexall and McKesson Canada's Retail Banner Group (Guardian®, IDA®, the Medicine Shoppe®, Remedy's Rx®) Ontario pharmacies will begin providing COVID-19 testing for asymptomatic individuals. In order to protect the health and safety of customers, patients and employees, COVID-19 testing within pharmacies must be made through appointment only.

"Pharmacists are increasingly taking on expanded roles in the Canadian healthcare system, while being recognized as essential partners in care delivery," said Rebecca McKillican, CEO, McKesson Canada. "We welcome today's news from the Government of Ontario, instilling confidence in our pharmacists as they continually step up on the frontlines to stop the spread of COVID-19 in our communities."

McKesson Canada is currently supporting COVID-19 testing for asymptomatic patients in Alberta, where IDA®, Guardian®, Remedy's Rx®, the Medicine Shoppe® and Rexall® pharmacies were early adopters as part of the province's original pilot program. McKesson Canada's network of participating pharmacies have conducted thousands of tests to date, and will use the training, tools, and supports developed to ensure best practices are implemented in Ontario.  

"Community pharmacists are proud to be supporting the province's efforts in the fight against COVID-19," continued McKillican. "Increasing the availability of testing is an important step to protect families, loved ones, and the people we encounter on a daily basis."

COVID-19 testing increases Ontario's ability to determine the prevalence of the infection across the province's population and to understand the spread and presence of COVID-19. For more information on which locations offer COVID-19 testing to asymptomatic patients, please visit
https://news.ontario.ca/en/release/58492/ontario-expands-covid-19-testing-to-pharmacies.

 

About McKesson Canada
Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586

Mckesson Canada Prepares to Support the Distribution of a Future COVID-19 Vaccine in Canada

Canada's largest pharmaceutical distributor commits to working with federal, provincial and territorial governments to ensure that Canada is ready to deliver a future COVID-19 vaccine from coast to coast to coast

 

MISSISSAUGA, ON, Sept. 16, 2020 /CNW Telbec/ - As the Government of Canada continues to procure future COVID-19 vaccines, McKesson Canada, the country's largest pharmaceutical distributor, is preparing to safely deliver it to communities and Canadians across the country.

McKesson Canada is the only pharmaceutical distributor in the country with existing Health Canada-licensed infrastructure that reaches every province and territory and is uniquely positioned to ensure the safe and effective delivery of a COVID-19 vaccine once it becomes available.

"We are a natural partner for government to ready Canada for a future COVID-19 vaccine," said Rebecca McKillican, CEO, McKesson Canada. "For over 100 years, McKesson Canada has worked with leading pharmaceutical manufacturers to deliver medications and complex therapies to Canadians, including those companies with a potential COVID-19 vaccine."

McKesson Canada looks forward to collaborating with federal, provincial and territorial governments to design a vaccine distribution model that builds on the strengths of the public and private-sector vaccine supply chains to support what will be the greatest public health distribution in Canadian history.

In the United States, McKesson Corporation was selected by the Centers for Disease Control and Prevention (CDC) to act as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations.

"Since the onset of the pandemic, McKesson Canada has leveraged its deep expertise to help maintain the integrity of the healthcare and pharmaceutical supply chain, source and distribute personal protective equipment to frontline workers, and stand up COVID-19 testing in pharmacies, many in underserved communities," said McKillican. "We are proud to support community pharmacy as the most convenient, accessible, and popular immunization points via our safe, secure, and efficient vaccine distribution model, as we do every year for influenza."

In 2009, during the H1N1 pandemic, McKesson Canada supported federal, provincial and territorial governments in the distribution of antiviral drugs to pharmacies and hospitals as the country fought against the disease.

Today, McKesson Canada is responsible for delivering one-third of all medications needed daily in Canada to pharmacies and hospitals. Beyond that, McKesson Canada is a leading seasonal flu vaccine distributor in the country, distributing up to 1.5 million doses annually.

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586